Lentigo Maligna: Diagnosis and Treatment

Clinics in Plastic Surgery

Volumn 37, Issue 1, 2010, Pages 35-46

  Bosbous, Mark W ^a   Dzwierzynski, William W ^a   Neuburg, Marcelle ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Diagnosis; Lentigo maligna; Lentigo maligna melanoma; Melanoma in situ; Treatment

Indexed keywords

ALPHA INTERFERON; IMIQUIMOD; IMMUNOMODULATING AGENT; LIQUID NITROGEN;

CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOSURGERY; CLINICAL FEATURE; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG RESPONSE; EXCISION; HISTOPATHOLOGY; HUMAN; LOW LEVEL LASER THERAPY; MALIGNANT LENTIGO; RECURRENCE RISK; REVIEW; SEX DIFFERENCE; SKIN SURGERY; SURGICAL TECHNIQUE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MELANOMA; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 70449382397     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2009.08.006     Document Type: Review

References (75)

1. Agarwal-Antal N., Bowen G.M., and Gerwela J.W. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol 47 (2002) 743-748
2. Clark Jr. W.H., Elder D.E., and Van Horn M. The biologic forms of malignant melanoma. Hum Pathol 17 (1986) 443-450
3. Langley R.G.B., Flotte T.J., and Sober A.J. Clinical characteristics. In: Balch C.M.H.A., Sober A.J., and Soong S. (Eds). Cutaneous melanoma (1998), Quality Medical Publishing Incorporated, St. Louis (MO) 81-101
4. McKenna J.K., Florell S.R., Goldman G.D., et al. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg 32 (2006) 493-504
5. Cohen L.M. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 33 (1995) 923-936
6. Newell G.R., Sider J.G., Bergfelt L., et al. Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res 48 (1988) 5036-5041
7. Kuflik E.G., and Gage A.A. Cryosurgery for lentigo maligna. J Am Acad Dermatol 31 1 (1994) 75-78
8. Pitman G.H., Kopf A.W., Bart R.S., et al. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol 5 (1979) 727-737
9. Bartoli C., Bono A., Clemente C., et al. Clinical diagnosis and therapy of cutaneous melanoma in situ. Cancer 77 (1996) 882-892
10. Zalaudek I., Horn M., Richtg E., et al. Local recurrence in melanoma in situ: influence of sex, age, site of involvement, and therapeutic modalities. Br J Dermatol 148 (2003) 703-708
11. Hutchinson J. On tissue dotage. Arch Surg (London) 3 (1892) 315-332
12. Dubreuilh M.W. Lentigo malin de vieillards. Ann Dermatol Syphiligr 3 (1894) 1092-1099
13. Dubreuilh M.W. De la melanose circonscrite precancereuse. Ann Dermatol Syphil 5 (1912) 129-151 205-30
14. Nestle F.O., and Kerl H. Melanoma. In: Bolognia J.L., Jorizzo J.L., and Rapini R.P. (Eds). Dermatology. 1st edition volume 2 (2003), Mosby, Philadelphia 1789-1815
15. Cox N.H., Aitchison T.C., Sirel J.M., et al. Comparison between lentigo maligna melanoma and other histogenic types of malignant melanoma of the head and neck. Br J Cancer 73 (1996) 940-944
16. Swetter S.M., Boldrick J.C., Jung S.Y., et al. Increasing Incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 125 (2005) 685-691
17. Temple C.L., and Arlette J.P. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J Surg Oncol 94 (2006) 287-292
18. Holman C.D., Mulroney C.D., and Armstrong B.K. Epidemiology of preinvasive and invasive malignant melanoma in western Australia. Int J Cancer 25 (1980) 317-323
19. Bienert T.N., Trotter M.J., and Arlette J.P. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg 7 (2003) 25-30
20. Arlette J.P., Trotter M.J., Trotter T., et al. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology. J Surg Oncol 86 (2004) 179-186
21. Su W.P., and Bradely R.R. Amelanoic lentigo maligna. Arch Dermatol 116 1 (1980) 82-83
22. Rahbari H., Nabai H., Mehregan A., et al. Amelanotic lentigo maligna melanoma: a diagnostic conundrum-presentation of four new cases. Cancer 77 10 (1998) 2052-2057
23. Fleming C.J., Bryden A.M., Evans A., et al. A pilot study of treatment of lentigo maligna with 5% imiquimod cream. Br J Dermatol 151 (2004) 485-488
24. Cognetta Jr. A.B., Stolz W., Katz B., et al. Dermatoscopy of lentigo maligna. Dermatol Clin 19 2 (2001) 307-318
25. Stante M., Giorgi V., Stanganelli I., et al. Dermoscopy for early detection of facial lentigo maligna. Br J Dermatol 152 (2005) 361-364
26. Chen C.S., Elias M., Busam K., et al. Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma. Br J Dermatol 153 5 (2005) 1031-1036
27. Clark Jr. W.H., and Mihm Jr. M.C. Lentigo maligna and lentigo maligna melanoma. Am J Pathol 55 (1969) 39
28. Weyers W., Bonczkowitz M., Weyers I., et al. Melanoma in situ versus melanocytic hyperplasia in sun damaged skin. Am J Dermatopathol 18 (1996) 560-566
29. Farrahi F., Egbert B.M., and Swetter M. Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathalogic distinction. J Cutan Pathol 32 6 (2005) 405-412 Erratum in: J Cutan Pathol 2005;32(7):521
30. Barnhill R.L., and Mihm Jr. M.C. The histopathology of cutaneous malignant melanoma. Semin Diagn Pathol 10 (1993) 47-75
31. Flotte T.J., and Mihm M.C. Lentigo maligna and malignant melanoma in situ, lentigo maligna type. Hum Pathol 30 (1999) 533-536
32. Malhotra R., Chen C., Huilgol S., et al. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology 110 (2003) 2011-2018
33. Walling H.W., Scupham R.K., Bean A.K., et al. Staged Excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 57 4 (2007) 659-664
34. Johnson T.M., Headington J.T., Baker S.R., et al. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the square procedure. J Am Acad Dermatol 37 (1997) 758-764
35. Wildemore J.K., Schuchter L., Mick R., et al. Locally recurrent malignant melanoma-characteristics and outcomes: a single-institution study. Ann Plast Surg 55 (2002) 611-615
36. Miescher G. Uber Melanotische Precancerose [Melanotic Precancerosis]. Oncologia 7 (1954) 92-94 [in German]
37. Miecher G. Die Behandlung der Malingnen Melanome der Haut mit EinschluB der Melanotischen Pracancerose [The treatment of malignant melanoma of the skin including the melanotic precancerous stage]. Strahlentherapie 46 (1960) 25-35 [in German]
38. Wilson L. Radiation therapy. In: Bolognia J.L., Jorizzo J.L., and Rapini R.P. (Eds). Dermatology. 1st edition volume 2 (2003), Mosby, Philidelphia 2185-2195
39. Schmid-Wendtner M.H., Brunner B., Konz B., et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J Am Acad Dermatol 43 3 (2000) 477-482
40. Farshad A., Burg G., and Panizzon R. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft x-rays. Br J Dermatol 143 (2002) 843-845
41. Harwood A.R. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 6 (1982) 310-316
42. Tsang R.W., Liu F.F., Wells W., et al. Lentigo maligna of the head and neck. Arch Dermatol 130 (1994) 1008-1012
43. Machado de Moreas A., Pavarin L.B., Herreros F., et al. Cryosurgical treatment of lentigo maligna. JDDG 5 (2007) 477-481
44. Arndt K.A. New pigmented macule appearing four years after argon laser treatment of lentigo maligna. J Am Acad Dermatol 14 (1986) 1092
45. Kopera D. Treatment of lentigo maligna with carbon dioxide laser. Arch Dermatol 131 6 (1995) 735-736
46. Orten S.S., Waner M., and Dinehart S.M. Q switched neodymium; yttrium-aluminum-garnet laser treatment of lentigo maligna. Otolaryngol Head Neck Surg 120 (1999) 296-302
47. Kauvar A.N.B., and Geronemus R.G. Treatment of lentigo maligna with the Q-switched ruby laser. Lasers Surg Med 7 (1995) 48
48. Cornejo P., Vanaclocha F., and Polimon I. Intralesional interferon treatment of lentigo maligna. Arch Dermatol 136 (2000) 428-430
49. Iyer S., and Goldman M.P. Treatment of lentigo maligna with combination laser therapy: recurrence at 8 months after initial resolution. J Cosmet Laser Ther 5 (2003) 49-52
50. Carucci J.A., and Leffell D.J. Intralesional interferon for treatment of recurrent lentigo maligna for the eyelid in a patient with primary melanosis. Arch Dermatol 136 (2000) 1415-1416
51. Naylor M.F., Crowson N., Kuwahara R., et al. Treatment of lentigo maligna with topical imiquimod. Br J Dermatol 149 Suppl 66 (2003) 66-69
52. van Meurs T., van Doorn R., and Kirtschig G. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. Dermatol Surg 33 5 (2007) 623-627
53. Cotter M.A., McKenna J.K., and Bowen G.M. Treatment of lentigo maligna with imiquimod before staged excision. Dermatol Surg 34 2 (2007) 147-151
54. National Institutes of Health Consensus Development Conference Statement on diagnosis and treatment of early melanoma. Am J Dermatopathol 15 (1993) 34-43
55. NCCN clinical practice guidelines in oncology: melanoma V.2.2008. Available at:. http://www.nccn.org/prefessionals/physician_gls/PDF/melanoma.pdf Accessed August 5, 2008
56. Osborne J.E., and Hutchison P.E. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg 55 (2002) 611-615
57. Hazan C., Dusza S., Delgado R., et al. Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases. J Am Acad Dermatol 58 1 (2008) 142-148
58. Zitelli J.A., Brwon C.D., and Hanusa B.H. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol 37 (1997) 422-429
59. Zitelli J.A., Brown C., and Hanusa B.H. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 37 (1997) 236-245
60. Robinson J.K. Margin control for lentigo maligna. J Am Acad Dermatol 31 (1994) 79-85
61. Zalla M.J., Lim K.K., Dicaudo D.J., et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 26 (2000) 771-784
62. Cohen L.M., McCall M.W., Hodge S.J., et al. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs micrographic surgery aided by rush permanent section. Cancer 73 12 (1994) 2964-2970
63. Zitelli J.A., Mow R.L., and Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 24 (1991) 102-106
64. Barlow R.J., White C.R., and Swanson N.A. Mohs micrographic surgery using frozen section alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol 146 (2002) 290-294
65. Florell S.R., Boucher K.M., and Leachman S.A. Histopathologic recognition of involved margins of lentigo maligna excised by staged excision: an interobserver comparison study. Arch Dermatol 139 (2003) 595-604
66. Bricca G.M., Brodland D.J., and Ren D. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol 52 (2005) 92-100
67. Bhardwaj S.S., Tope W.D., and Lee P.K. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol Surg 32 (2006) 690-697
68. Shabrawi-Caelen L.E., Kerl H., and Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun damaged skin and actinic keratosis. Am J Dermatopathol 26 (2004) 364-366
69. Stonecipher M.R., Leshin B., Patrick J., et al. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections. J Am Acad Dermatol 29 4 (1994) 589-594
70. Cohen L.M., McCall M.W., and Zax R.H. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma: a follow-up study. Dermatol Surg 24 (1998) 673-677
71. Clayton B.D., Leshin B., Hitchcock M.G., et al. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 26 (2000) 671-678
72. Mahoney M.H., Josephy M., and Temple C.L.F. The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery. J Surg Oncol 91 (2005) 120-125
73. Bub J.L., Berg D., Slee A., et al. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow up. Arch Dermatol 140 (2004) 552-558
74. Huilgol S.C., Selva D., Chen C., et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol 140 (2004) 1087-1092
75. Jejurikar S.S., Borschel G.H., Johnson T.M., et al. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plastic and Reconstructive Surgery 120 5 (2007) 1249-1255